Bausch + Lomb Corp (BLCO) - Total Liabilities

Latest as of September 2025: CA$7.33 Billion CAD ≈ $5.30 Billion USD

Based on the latest financial reports, Bausch + Lomb Corp (BLCO) has total liabilities worth CA$7.33 Billion CAD (≈ $5.30 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore BLCO year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Bausch + Lomb Corp - Total Liabilities Trend (2019–2024)

This chart illustrates how Bausch + Lomb Corp's total liabilities have evolved over time, based on quarterly financial data. See Bausch + Lomb Corp free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Bausch + Lomb Corp Competitors by Total Liabilities

The table below lists competitors of Bausch + Lomb Corp ranked by their total liabilities.

Company Country Total Liabilities
QuantumCTek Co Ltd
SHG:688027
China CN¥344.40 Million
Shenergy Co Ltd
SHG:600642
China CN¥60.73 Billion
Elis SA
PA:ELIS
France €5.76 Billion
Matador Resources Company
NYSE:MTDR
USA $6.26 Billion
Nestle (Malaysia) Bhd
KLSE:4707
Malaysia RM2.96 Billion
Inner Mongolia Dazhong Mining Co Ltd
SHE:001203
China CN¥10.41 Billion
Stonex Group Inc
NASDAQ:SNEX
USA $50.93 Billion
BOC Aviation Limited
F:8BO
Germany €19.50 Billion

Liability Composition Analysis (2019–2024)

This chart breaks down Bausch + Lomb Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BLCO company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.51 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.14 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.53 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bausch + Lomb Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bausch + Lomb Corp (2019–2024)

The table below shows the annual total liabilities of Bausch + Lomb Corp from 2019 to 2024.

Year Total Liabilities Change
2024-12-31 CA$6.92 Billion
≈ $5.01 Billion
+6.18%
2023-12-31 CA$6.52 Billion
≈ $4.72 Billion
+61.32%
2022-12-31 CA$4.04 Billion
≈ $2.92 Billion
+184.52%
2021-12-31 CA$1.42 Billion
≈ $1.03 Billion
+11.19%
2020-12-31 CA$1.28 Billion
≈ $924.49 Million
-11.00%
2019-12-31 CA$1.44 Billion
≈ $1.04 Billion
--

About Bausch + Lomb Corp

TO:BLCO Canada Medical Instruments & Supplies
Market Cap
$6.06 Billion
CA$8.38 Billion CAD
Market Cap Rank
#3140 Global
#105 in Canada
Share Price
CA$23.66
Change (1 day)
-0.42%
52-Week Range
CA$18.76 - CA$25.41
All Time High
CA$29.30
About

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily d… Read more